0.290
0.06 (23.40%)
| Previous Close | 0.235 |
| Open | 0.270 |
| Volume | 55,194 |
| Avg. Volume (3M) | 67,142 |
| Market Cap | 63,732,792 |
| Price / Earnings (Forward) | 0.200 |
| Price / Sales | 0.600 |
| Price / Book | 1.51 |
| 52 Weeks Range | |
| Earnings Date | 22 Jul 2025 - 28 Jul 2025 |
| Profit Margin | -5.98% |
| Operating Margin (TTM) | 2.63% |
| Diluted EPS (TTM) | -0.050 |
| Quarterly Revenue Growth (YOY) | 19.10% |
| Total Debt/Equity (MRQ) | 12.45% |
| Current Ratio (MRQ) | 1.81 |
| Operating Cash Flow (TTM) | 2.32 M |
| Levered Free Cash Flow (TTM) | -6.86 M |
| Return on Assets (TTM) | -2.14% |
| Return on Equity (TTM) | -15.51% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (AU) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | SOMNOMED FPO [SOM] | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Relative Valuation | NA |
| Financial Health | -2.5 |
| AI Insight | NA |
| Weighted Average | -0.28 |
Select this tab to load the latest available analysis.
|
SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 20.13% |
| % Held by Institutions | 57.68% |
No data within this time range.
No data within this time range.
AI Technical Analysis
Open the Technical tab to generate the latest analysis.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |